Search Within

Ana Maria Luisa Molina

Formats
  1. Meeting Abstract (31)
  2. Journal Article (19)
Groups
  1. Department of Medicine (47)
  2. Solid Tumor Oncology Division (45)
  3. Genitourinary Oncology Service (44)
  4. Epidemiology and Biostatistics (21)
  5. Biostatistics Service (20)
  6. Radiology, Department of (16)

More Groups

People
  1. Robert Motzer (38)
  2. Sujata Patil (19)
  3. Darren Feldman (17)
  4. Martin Voss (11)
  5. Michelle Ginsberg (8)
  6. Xiaoyu Jia (8)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (4)
  4. 2015 (5)
  5. 2014 (6)
  6. 2013 (8)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Clinical Genitourinary Cancer (3)
  3. Annals of Oncology (2)
  4. Blood (2)
  5. Cancer Chemotherapy and Pharmacology (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Elsevier Inc. (6)
  3. Springer (4)
  4. Oxford University Press (3)
  5. American Association for Cancer Research (2)
  6. American Society of Hematology (2)

More Publishers

Results (50)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel
    Meeting Abstract

    Scher, H. I.; Heller, G.; Molina, A.; Kheoh, T. S.; Attard, G.; Moreira, J.; Sandhu, S. K.; Parker, C.; Logothetis, C.; McCormack, R. T.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Molecular classification of sunitinib response in metastatic renal cell carcinoma (mRCC) patients by gene expression profiling
    Meeting Abstract

    Thodima, V. J.; Molina, A. M.; Jia, X.; Zhang, J.; Georges, M. E.; Patil, S.; Reuter, V. E.; Motzer, R. J.; Chaganti, R. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Long-term response to sunitinib for metastatic renal cell carcinoma (mRCC) patients treated on clinical trials at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Molina, A. M.; Jia, X.; Ginsberg, M. S.; Velasco, S.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Fischer, P.; Trinos, M. J.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib
    Journal Article

    Molina, A. M.; Ginsberg, M. S.; Motzer, R. J.
    Medical Oncology (2011)

    Fulltext@MSK | Save
  • Sarcomatoid-variant renal cell carcinoma: Treatment outcome and survival in advanced disease
    Journal Article

    Molina, A. M.; Tickoo, S. K.; Ishill, N.; Trinos, M. J.; Schwartz, L. H.; Patil, S.; Feldman, D. R.; Reuter, V. E.; Russo, P.; Motzer, R. J.
    American Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • MTOR inhibitors in advanced renal cell carcinoma
    Journal Article

    Voss, M. H.; Molina, A. M.; Motzer, R. J.
    Hematology/Oncology Clinics of North America (2011)

    Fulltext@MSK | Save
  • Clinical practice guidelines for the treatment of metastatic renal cell carcinoma: today and tomorrow
    Journal Article

    Molina, A. M.; Motzer, R. J.
    The Oncologist (2011)

    Fulltext@MSK | Save
  • Long-term responders to sunitinib therapy for metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Molina, A. M.; Jia, X.; Ginsberg, M. S.; Velasco, S.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Molecular profiling of circulating tumor cells (CTC) in patients with castrate metastatic prostate cancer (CMPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy
    Meeting Abstract

    Danila, D. C.; Anand, A.; Sung, C. C.; Leversha, M.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Molina, A.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save